Difference between revisions of "Part:BBa K2549005:Design"

(→‎References)
(→‎Design Notes)
Line 7: Line 7:
  
 
===Design Notes===
 
===Design Notes===
−
Its heavy-chain variable region(αCD19a) and light-chain variable region(αCD19b) are fused using a glycine-rich peptide linker(3 repeats of GGGGS, or G4S).
+
Its heavy-chain variable region(αCD19a) and light-chain variable region(αCD19b) are fused using a glycine-rich peptide linker(3 repeats of GGGGS, or G4S)[1].
−
 
+
−
 
+
  
 
===Source===
 
===Source===

Revision as of 11:17, 6 October 2018


anti-CD19


Assembly Compatibility:
  • 10
    COMPATIBLE WITH RFC[10]
  • 12
    COMPATIBLE WITH RFC[12]
  • 21
    COMPATIBLE WITH RFC[21]
  • 23
    COMPATIBLE WITH RFC[23]
  • 25
    COMPATIBLE WITH RFC[25]
  • 1000
    INCOMPATIBLE WITH RFC[1000]
    Illegal BsaI site found at 444


Design Notes

Its heavy-chain variable region(αCD19a) and light-chain variable region(αCD19b) are fused using a glycine-rich peptide linker(3 repeats of GGGGS, or G4S)[1].

Source

IDT(gBlock)

References

[1]Chimeric Antigen Receptor-Modified T Cells in Chronic Lymphoid Leukemia; Chimeric Antigen Receptor-Modified T Cells for Acute Lymphoid Leukemia; Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia. . N Engl J Med, 2016 Mar;374(10):998 PMID: 26962747; DOI: 10.1056/NEJMx160005